Navigation Links
Idenix Retains Worldwide Rights to Develop and Commercialize IDX184 for the Treatment of HCV
Date:10/29/2009

by the use of forward-looking terminology such as "expect," "plans," "anticipates," "will," "expects," "goal" or similar expressions, or by express or implied statements with respect to the company's clinical development programs or commercialization activities in hepatitis C, or any potential pipeline candidates, including any expressed or implied statements regarding the efficacy and safety of IDX184, or any other product candidate and any future clinical trials involving our product candidates and expectations with respect to additional milestone payments, future royalty payments, funding of operations and future cash balances. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantees that the company will advance any clinical product candidate or other component of its potential pipeline to the clinic, to the regulatory process or to commercialization. In particular, management's expectations could be affected by unexpected regulatory actions or delays; uncertainties relating to, or unsuccessful results of, clinical trials, including additional data relating to the ongoing clinical trials evaluating its product candidates; the company's ability to obtain additional funding required to conduct its research, development and commercialization activities; changes in the company's business plan or objectives; the ability of the company to attract and retain qualified personnel; competition in general; and the company's ability to obtain, maintain and enforce patent and other intellectual property protection for its product candidates and its discoveries. These and other risks which may impact management's expectations are described in greater detail under the caption "Risk Factors" in the company's annual report on Form 10-K for the year ended December 3
'/>"/>
SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Idenix Announces Data Presentations at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
2. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
3. Idenix Pharmaceuticals Prices Underwritten Offering of Common Stock
4. Idenix Pharmaceuticals Reports Second Quarter and Six Month 2009 Financial Results
5. Idenix to Host Conference Call Discussing Second Quarter 2009 Financial Results
6. Idenix Pharmaceuticals to Present at The Deutsche Bank 2009 Health Care Conference
7. Idenix Pharmaceuticals Reports First Quarter Financial Results
8. Idenix Pharmaceuticals Reports Data From Three Hepatitis C Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver
9. Idenix Pharmaceuticals to Present at the Canaccord Adams Hepatitis C Conference
10. Idenix Announces Data Presentations from Three HCV Discovery and Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL)
11. Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... ... July 07, 2015 , ... An aging population, ... of the factors driving the pharmaceutical contract manufacturing market. BCC Research reveals in ... manufacturing organizations (CMOs), are driving market growth. Drug manufacturers are increasing their outsourcing ...
(Date:7/7/2015)... 7, 2015  Neogen Corporation (NASDAQ: NEOG ) ... expand its relationship with Illumina (NASDAQ: ILMN ), ... agreement, Illumina will market and sell arrays with Neogen,s ... BeadArray technology, to the global agrigenomics community. ... its GeneSeek ® genomics laboratory in ...
(Date:7/7/2015)... ... , ... Since its inception in 2004 PhUSE has become ... conference for European Statistical Programmers, has evolved in the past eleven years to ... Data Managers and Biostatisticians all over the world, share, contribute and advance at ...
(Date:7/6/2015)... Worcester, Mass. (PRWEB) , ... July 06, 2015 ... ... by Worcester Polytechnic Institute (WPI), offers new insights into how virulent fungi adapt ... block their spread, and how that battle leaves them temporarily weakened. These insights ...
Breaking Biology Technology:More Drug Companies Increasing Outsourcing Budgets; CMO Partners Spring Up as Market Thrives, According to BCC Research 2More Drug Companies Increasing Outsourcing Budgets; CMO Partners Spring Up as Market Thrives, According to BCC Research 3Neogen signs commercialization agreement with Illumina 2PhUSE Delighted to Welcome Member Number 5.000 2Worcester Polytechnic Institute Co-directs Study That Provides New Insights into the Genetics of Drug-Resistant Fungal Infections 2Worcester Polytechnic Institute Co-directs Study That Provides New Insights into the Genetics of Drug-Resistant Fungal Infections 3Worcester Polytechnic Institute Co-directs Study That Provides New Insights into the Genetics of Drug-Resistant Fungal Infections 4
... for the Federal Circuit (CAFC) issued a patent-law decision last ... worthless, and that will raise the bar for proving gene ... whether certain gene fragment sequences were useful. Most notably whether ... required by U.S. patent law. , ,The CAFC ruled against ...
... , Wis. - Three UW-Madison scientists have ... into pancreatic islet cells, the Wisconsin Alumni Research Foundation ... to greatly increase the number of islet cells available for ... Odorico , Brenda W. Kahan, and Nathan R. Treff, have ...
... include more biobased fuels to reduce the state's reliance ... policy initiative, consortium and related bill from Madison explore ... major industrial sectors into the alternative energy market. ... find out where in that whole mix is Wisconsin's ...
Cached Biology Technology:Court bars patent protection for certain gene fragments 2Court bars patent protection for certain gene fragments 3Court bars patent protection for certain gene fragments 4Biofuels surge forward 2Biofuels surge forward 3Biofuels surge forward 4
(Date:6/23/2015)... June 23, 2015   Valencell, a ... results of a recent study that illustrates its ... wrist during activity. In a study conducted at ... along with the Apple Watch against a chest ... rate during activity. The study demonstrated that Valencell,s ...
(Date:6/18/2015)... , June 18, 2015 NXT-ID, Inc. (NASDAQ: ... focused on the growing mobile commerce market announces that its ... segment on "Money on the Mark", scheduled to air on ... June 20 th . The broadcast ... from 7:00 to 8:00pm EST. NXT-ID, Inc.,s CEO Gino ...
(Date:6/17/2015)... , June 17, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced that Xiaomi, one of the ... ® ClearPad ® family of capacitive ... integrated circuits (DDICs) for its latest smartphones, the ... ClearPad for full in-cell display solutions and DDICs ...
Breaking Biology News(10 mins):Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 2Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 3
... and conducted by scientists Carlos Duarte, Nuria Agust and ... Studies (CSIC University of the Balearic Islands) has ... explains the equilibrium of plant communities, showing how plants ... last a day or are prolonged over centuries. ...
... A groundbreaking environmental study to be published in a ... will end up in fish in as little as ... Edmonton, Canada, played a key role in designing and ... if mercury emissions from coal-fired power plants and other ...
... working to produce cheap, sustainable solar energy by imitating ... Nate Lewis are exploring nanoscale materials that mimic the ... the suns energy. A new podcast looks ... are trying to imbed tiny nanoparticles into simple, inexpensive ...
Cached Biology News:A study proposes a new universal rule to explain the equilibrium of plant populations 2
The Bio-Plex Manager version 3.0 to 4.0 workstation software upgrade kit is used to upgrade existing Bio-Plex Manager version 3.0 software to version 4.0 security edition software....
... of 3 siRNAs specifically targeted to your ... product. The siTrio reagent guarantees you get ... gene when used under standard conditions (100 ... optimal transfection with one of B-Bridges controls). ...
... 25-Hydroxy Vitamin D kit is an ... of 25-hydroxyvitamin D (25-OH D) and ... or plasma. Our patented DIRECT assay ... precipitation and centrifugation and therefore facilitates ...
Mouse monoclonal [BC-4] to Aggrecan xxPEN ( Abpromise for all tested applications). entrezGeneID: 176 SwissProtID: P16112...
Biology Products: